416 related articles for article (PubMed ID: 27259043)
1. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
[TBL] [Abstract][Full Text] [Related]
2. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
3. A Polysaccharide Purified From
Lin YL; Shih C; Cheng PY; Chin CL; Liou AT; Lee PY; Chiang BL
Front Immunol; 2020; 11():561758. PubMed ID: 33117346
[TBL] [Abstract][Full Text] [Related]
4. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
[TBL] [Abstract][Full Text] [Related]
5. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R
J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926
[TBL] [Abstract][Full Text] [Related]
6. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.
Zhang F; Hao C; Zhang S; Li A; Zhang Q; Wu W; Liu L; Li C; Liang M; Li X; Li D
Virol J; 2014 May; 11():80. PubMed ID: 24885121
[TBL] [Abstract][Full Text] [Related]
8. Immune responses against enterovirus A71 infection: Implications for vaccine success.
Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
[TBL] [Abstract][Full Text] [Related]
9. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ
Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan.
Huang LM; Chiu CH; Chiu NC; Lin CY; Li MT; Kuo TY; Weng YJ; Hsieh EF; Tai IC
Vaccine; 2019 Mar; 37(13):1827-1835. PubMed ID: 30803843
[TBL] [Abstract][Full Text] [Related]
12. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice.
Zhang C; Zhang X; Zhang W; Dai W; Xie J; Ye L; Wang H; Chen H; Liu Q; Gong S; Geng L; Huang Z
Emerg Microbes Infect; 2018 Jan; 7(1):3. PubMed ID: 29323105
[TBL] [Abstract][Full Text] [Related]
13. Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.
Premanand B; Prabakaran M; Kiener TK; Kwang J
PLoS One; 2013; 8(2):e55536. PubMed ID: 23390538
[TBL] [Abstract][Full Text] [Related]
14. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71.
Yu Z; Huang Z; Sao C; Huang Y; Zhang F; Ma G; Chen Z; Zeng Z; Qiwen D; Zeng W
Arch Virol; 2013 May; 158(5):1071-7. PubMed ID: 23275129
[TBL] [Abstract][Full Text] [Related]
15. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
[TBL] [Abstract][Full Text] [Related]
16. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71.
Chiu CH; Chu C; He CC; Lin TY
Microbes Infect; 2006 Jun; 8(7):1671-8. PubMed ID: 16815726
[TBL] [Abstract][Full Text] [Related]
17. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
[TBL] [Abstract][Full Text] [Related]
19. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
